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We have purrfied vasoactrve polypetrdes from the urme of normotensrve humans by gel filtratron on Sepha- 
dex G150 superfine romc exchange chromatography on DEAE-cellulose and rsoelectnc focusing m poly- 
acrylamrde gels usmg a pharmalyte pH range of 2.5-5.0 The purified polypetrde fraction yrelded four bands 
by rsoelectrrc focusing with rsoelectrrc pomts at pH 4 15, 4 05, 3 9 and 3 8 On dodecyl sulphate/polyacryl- 
amide gel electrophoresrs (page) two bands appeared, one small band wrth a M, of 29 000 and one broad 
band rangmg from M,49 000 to M,42 500 The polypetrdes lower the blood pressure of rabbits m a bioassay 
and cleave D-valyl-L-leucyl-L-argmme-4-mtroanihde with a specrfic actrvrty comparable to that of kal- 
hkrem 
Human urine Vasoactlve polypeptrde Kalhkrem 
1. INTRODUCTION 
The urine of normotensive human beings con- 
tains a polypeptide fraction with blood pressure 
lowering activity [l-4]. It is of particular interest 
that the vasoactivrty of this polypeptrde fraction 
was shown to be impaired in patients with primary 
hypertension [5,6]. Furthermore, it was found that 
the urine fraction from patients with primary 
hypertension and from normotensive individuals 
with a family history of hypertension failed to 
lower blood pressure in a rabbit bioassay system 
[6]. In the previous study from this laboratory [6] 
it was concluded that the vasoactrve principle was 
distinct from kallikrein based on enzymatic 
measurements of kallikrein-like activity. As defi- 
cient excretion of kalhkrein also has been im- 
plemented in the pathogenesis of primary 
hypertension [7] it was felt of particular impor- 
tance to isolate and characterize further the 
polypeptide fractron from the urine of normoten- 
sive individuals and to see whether, indeed, it can 
be distinguished from urinary kallikrem. 
2. MATERIALS AND METHODS 
2.1. Isolatron of unnary vasoactrve polypeptrdes 
Purification of the urinary vasoactive polypep- 
tides was as follows: the protein of 30 1 of the 24-h 
urine from normotensive human subjects was 
precipitated with ammonmm sulphate (650 g/l 
urine). The precipitate was dissolved in 600 ml of 
doubly distilled water, containing 7 mM 
2-mercaptoethanol. Portions of 60 ml were 
desalted by passing the samples over a Sephadex 
G25 medium (Pharmacia) (5 x 60 cm) column. 
After testing the vasodrlating activity of the salt- 
free fraction in a rabbit bioassay (see below) it was 
passed through a DEAE-cellulose (Whatman 
DE 52) (1.5 x 20 cm) column equilibrated with 
10 mM NH4-acetate, 7 mM 2-mercaptoethanol, 
pH 5.5. The retained proteins were eluted with 1 M 
NH&l, 7 mM 2-mercaptoethanol, pH 5.5. Both 
fractions, the run-off fraction and the eluate, were 
tested in the rabbrt bioassay. Portions (20 ml) of 
the eluted vasoactive fraction containing acidic 
proteins were chromatographed on a Sephadex 
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G150 superfine (Pharmacta) (5 x 100 cm) column 
m 10 mM NH4-acetate, 7 mM 2-mercaptoethanol, 
pH 5.5. Fractions (5 ml) were tested in the rabbit 
bioassay. The vasoactive fractions were pooled 
and the material was passed through a DEAE- 
cellulose (Whatman DE 52) (1.5 x 20 cm) column 
equilibrated with 10 mM NH4-acetate, 7 mM 
2-mercaptoethanol, pH 5.5. The retained polypep- 
tides were eluted with a linear 5-500 mM NH&l 
equilibration buffer gradient. Fractions (4 ml) 
were tested in the rabbit bioassay. The vasoactlve 
fractions were pooled and the material was ex- 
haustively dialysed against doubly distilled Hz0 
containing 7 mM 2-mercaptoethanol. Dialysed 
material was Iyophilised and the powder was 
dissolved in 1 ml of a 1 in 15 dilution of phar- 
malyte covering a pH range from 2.5 to 5 and 15% 
sucrose. Portions of 0.5 ml were applied to a 
polyacrylamlde gel column (1.6 x 10 cm) and fur- 
ther fractionated by isoelectric focusing in a Phar- 
macia Gel Electrophoresis Apparatus GE-2/4LS 
(see [9]). The gel was cut m pieces according to pH 
and the proteins were eluted from the gel by elec- 
Froctmns (7ml) Fractlow (3mt) 
(a) (b) 
10 20 30 40 50 60 70 60 90 100 
trophoresls at 250 V for 12 h m a Pharmacla 
chamber GE-2/4LS using 50 mM Tris, 350 mM 
glycine. The eluates were dlalysed against doubly 
distilled water, containing 7 mM 2-mercapto- 
ethanol. The samples were then assayed for ac- 
tivity (see below) and analysed for protein by 
electrophoresis according to [9] and [12]. Protein 
concentratrons were determined using bovine 
serum albumin as standard [lo]. 
2.2. Blologrcal assay 
The fractions were tested for activity in a rabbit 
bioassay as described [6]. 
2.3. Cleavage of D-valyl-L-leucyl-L-argmine- 
4-nitroandrde 
Cleavage of the synthetic substrate D-Val-Leu- 
Arg-PNA was assayed according to [ 1 I]. 
3. RESULTS 
Fig.1 summarizes the elution profiles of the 
various chromatographic steps. The hatched 
- 
Fig. 1. The chromatographic purification of human 
urmary vasoactrve polypepttdes (a) Desalting. The 
protein m 30 1 urine was pelleted with ammomum 
sulphate and redissolved m H20, 7 mM 2-mercapto- 
ethanol as described m section 2. Portions (60 ml) were 
applied to a Sephadex G25 medium (5 x 60 cm) column 
and eluted with the same solution. Hatched peak I 
(protein peak) contains the activity. (b) Separation of 
neutral-basic from acidic urinary proteins. The desalted 
protein in 1050 ml of 10 mM N&-acetate, 7 mM 
2-mercaptoethanol, pH 5.5, was passed through a 
DEAE-cellulose (1.5 x 20 cm) column and eluted with 
1 M NH&l, 7 mM 2-mercaptoethanol, pH 5.5 Start of 
elutton IS indicated by the arrow. Hatched peak II (acidic 
proteins) contains the acttvity. (c) Fractionation of 
acidic urinary proteins. The proteins eluted m (b), 
(20 ml) in 1 M NI-LKl, 7 mM 2-mercaptoethanol, pH 
5.5, were applied to a Sephadex Gl50 superfine (5 x 
100 cm) column and eluted with 10 mM N&-acetate, 
7 mM 2-mercaptoethanol, pH 5.5. The hatched region 
of the elution profile contains the activity. (d) Fracttona- 
tton of active acidic urinary proteins. Protems from 
hatched regton of the elutton profile (c) m 450 ml of 
10 mM NH4-acetate, 7 mM 2-mercaptoethanol, pH 5.5, 
were passed through a DEAE-cellulose (1.5 x 20 cm) 
column and then eluted with a linear 5-500 mM NH&I 
equthbration buffer gradient. The activity was found m 
the hatched region of the elutron profile. 
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regions represent he vasoactive fractions. 
1 ml of the peak I-fraction in (a) lowered the 
blood pressure m the rabbit bioassay by 35%. 50 p1 
of the acidic protein fraction in (b) was equally ef- 
fective, while 1 ml of the neutral-basic proteins in 
the run off (peak I) was inactive. The acidic pro- 
teins were further fractionated on Sephadex G150 
superfine (c). 400~1 of the pooled vasoactrve 
material lowered the blood pressure of rabbits by 
36%. The vasoactive material from the Sephadex 
G150 column was fractionated on DEAE-cellulose 
(d). 40~1 of the vasoactive material lowered the 
blood pressure by 30% in the rabbit bioassay. 
The vasoactrve urinary polypeptides (from (d)) 
were fractionated m polyacrylamide gel by isoelec- 
tric focusing using a pharmalyte pH gradient. The 
vasoactive material was found in the pH range of 
3.5-4.5. As seen in ftg.2(a) it gives four diffuse 
bands with isoelectric points 4.15, 4.05, 3.9 and 
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Frg.2. (a) Isoelectrrc focusmg of the isolated vasoactrve 
human urinary proteins (from the pH range 3.5-4.5) in 
polyacrylanude gel using a pharmalyte pH range from 
2.5 to 5 accordrng to [9]. (b) SDS-PAGE of the purified 
vasoactive human urinary protems (found In the pH 
range 3.5-4.5) by the procedure in [12] Slot 1, 
vasoactrve protems. Slot 2, standard proteins, phos- 
phorylase b, albumin, ovalbumm, carbonic anhydrase, 
trypsm mhrbitor and ru-lactalbumm. 
3.8. Fig.2(b) shows a dodecyl sulphate-PAGE 
separation of the purified vasoactive polypeptides 
(from the pH range of 3.5-4.5) on a 15% 
polyacrylamide slab gel. The broad band A covers 
the M, range from 49000 to 42500. A smaller band 
B has an apparent molecular mass of 29 kDa. 
0.6/cg of the vasoactive material (from the pH 
range of 3.5-4.5) lowered the blood pressure in the 
rabbit bioassay by 32%. This polypeptide prepara- 
tion had a specific activity of 1.6 ~mol~min-‘- 
mg-’ protein measured with the model substrate 
D-Val-Leu-Arg-PNA, 
4. DISCUSSION 
As seen in frg.2(a) the vasoactive polypeptides 
from the urine of normotensive humans of both 
sexes (described [l-6]) are found in 4 major bands 
with Isoelectric points 4.15, 4.05, 3.9 and 3.8. 
Human urinary kallikrein, on isoelectric focusing 
in an ampholine pH gradient from 3 to 5, yields 6 
bands with isoelectric points 4.25, 4.05, 4.00, 3.9, 
3.8 and 3.75 [8]. Thus, the vasoactive proteins 
purified and characterised m this work and kalli- 
krem are similar with respect to their behavior on 
focusing. The vasoactrve proteins studied by us 
give, on dodecyl sulphate-PAGE [12], a very 
broad badly resolved band A spanning the molec- 
ular mass regron from 49 to 42.5 kDa. A smaller 
diffuse band B had an apparent M of 29000 
(frg.2(b)). Pure human urinary kallikrein, on 
dodecyl sulphate-PAGE [13], grves two bands 
with A4, values of 41000 and 34000 [8]. The dif- 
ferences in Mr of the vasoactive protems studied by 
us and kallikrein might be due however to the fact 
that analyses were carried out m different elec- 
trophoretic systems. Such differences were noted 
before [14]. 
0.6 pg of the vasoactive polypeptide preparation 
studied lowered the blood pressure in the rabbit 
bioassay by 32%. This preparatron cleaved 
1.6 pmol D-Val-Leu-Arg-PNA - mu- ’ - mg- ’ pro- 
tein. When human urinary kallikrem was tested in 
the rabbit bioassay and m cleavage of D-Val-Leu- 
Arg-PNA the same amount, 0.6 /cg, lowered the 
blood pressure by 35vo. Kallikrein cleaved 
1.8 pmol substrate - min-’ . mg-’ protein. Accor- 
dingly, the vasoactive proteins Isolated in this work 
and kallikrein have comparable biological and en- 
zymatrc activities. 
63 
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The vasoactive proteins from the urine of nor- 
motensive humans were isolated and characterised 
in this work as a group (fig.2(a)). It remams to 
characterrse the components of the group 
separated from each other. 
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